Ameriprise Financial Inc Adc Therapeutics Sa Transaction History

Ameriprise Financial Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.9 - $2.66 $44,422 - $62,190	-23,380 Reduced 20.71%	89,526 $192,000
Q1 2023 May 15, 2023	BUY	$1.92 - $5.45 $65,733 - $186,586	34,236 Added 43.52%	112,906 $220,000
Q4 2022 Feb 14, 2023	BUY	$2.87 - $5.24 $4,497 - $8,211	1,567 Added 2.03%	78,670 $302,000
Q3 2022 Nov 14, 2022	SELL	$4.66 - $10.31 $13,388 - $29,620	-2,873 Reduced 3.59%	77,103 $372,000
Q2 2022 Aug 15, 2022	BUY	$5.96 - $14.99 $29,478 - $74,140	4,946 Added 6.59%	79,976 $636,000
Q1 2022 May 16, 2022	BUY	$13.28 - $20.03 $115,243 - $173,820	8,678 Added 13.08%	75,030 $1.1 Million
Q4 2021 Feb 14, 2022	SELL	$19.29 - $31.51 $47,511 - $77,609	-2,463 Reduced 3.58%	66,352 $1.34 Million
Q3 2021 Nov 15, 2021	BUY	$20.45 - $30.0 $36,421 - $53,430	1,781 Added 2.66%	68,815 $1.87 Million
Q2 2021 Aug 16, 2021	BUY	$20.38 - $27.04 $114,433 - $151,829	5,615 Added 9.14%	67,034 $1.64 Million
Q1 2021 May 17, 2021	SELL	$22.75 - $34.05 $288,538 - $431,856	-12,683 Reduced 17.12%	61,419 $1.5 Million
Q4 2020 Feb 12, 2021	BUY	$25.26 - $38.02 $459,151 - $691,089	18,177 Added 32.5%	74,102 $2.37 Million
Q3 2020 Nov 16, 2020	SELL	$32.87 - $51.05 $288,762 - $448,474	-8,785 Reduced 13.58%	55,925 $1.85 Million
Q2 2020 Aug 14, 2020	BUY	$29.65 - $46.81 $1.92 Million - $3.03 Million	64,710 New	64,710 $3.03 Million

55.1M

82.7K

31.5K

Ticker ADCT
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,645,296
Market Cap $270M
Description
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.